Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Author
Nurbek Hamraev
Sep 22, 2023 1:33PM ET
20
2
1
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Final hours: unlock premium data with Claim 60% OFF
Boeing slashed to Hold on wider expected losses: 4 big analyst cuts
Published Sep 22, 2023 06:39AM ET
© Reuters.
By Davit Kirakosyan
Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Boeing, Deere, Travere Therapeutics, and Community Healthcare Trust.
InvestingPro subscribers got this news first. Never miss another market-moving headline.
Boeing slashed to Hold
CFRA downgraded Boeing (NYSE:BA) to Hold from Buy and cut its price target to $210.00 from $253.00.
The firm revised its earnings estimates, with an increased expected loss per share in 2023 of ($3.29) and a reduced earnings per share estimate for 2024 of $5.39.
BA guided for deliveries of its family of 737 planes at 50 per month by the 2025-2026 time frame, which still affords time to resolve issues, but we note that (1) current guidance remains below early '19 guidance levels, despite more runway to get there; and (2) BA shares already fetch a higher multiple today than in early '19.
Despite these concerns, CFRA acknowledges the long-term potential for aircraft demand, with an estimated 76% of the 2022 global fleet likely to require replacement by 2042, presenting opportunities for Boeing.
Deere receives another downgrade
Canaccord Genuity downgraded Deere (NYSE:DE) to Hold from Buy and cut its price target to $400.00 from $530.00, as reported in real-time on InvestingPro.
Earlier this week, Evercore ISI downgraded the company to In Line from Outperform with a price target of $424.00 (from $456.00).
Two more downgrades
Travere Therapeutics (NASDAQ:TVTX) received two downgrades after the company posted mixed data from Phase 3 PROTECT Study of FILSPARI, which resulted in a 40% stock price drop yesterday.
Wells Fargo downgraded the company to Equal Weight from Overweight and cut its price target to $8.00 from $24.00. Meanwhile, William Blair downgraded the company to Market Perform from Outperform.
Baird downgraded Community Healthcare Trust (NYSE:CHCT) to Neutral from Outperform with a price target of $33.00.
Amid whipsaw markets and a slew of critical headlines, seize on the right timing to protect your profits: Always be the first to know with InvestingPro.
Start your free 7-day trial now.
Related Articles
Comments (1)
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.